134 related articles for article (PubMed ID: 2148733)
1. Comparison of some lymphocyte markers in B-cell chronic lymphocytic leukaemia and systemic lupus erythematosus (the B lymphocyte subset).
Magyarlaki T; Losonczy H; Pár A
Haematologia (Budap); 1990; 23(2):111-20. PubMed ID: 2148733
[TBL] [Abstract][Full Text] [Related]
2. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
3. Peripheral B-lymphocyte markers and function in IgA nephropathy.
Magyarlaki T; Davin JC; Szabados E; Kocsis B; Nagy J
Clin Nephrol; 1990 Mar; 33(3):123-9. PubMed ID: 2108834
[TBL] [Abstract][Full Text] [Related]
4. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
5. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
6. [Cytochemical detection of lymphocyte 5'-nucleotidase in chronic lymphatic leukemia].
Woessner S; Almarcha J; Marill MR; Florensa L; Besses C; Sans Sabrafén J
Sangre (Barc); 1991 Aug; 36(4):301-4. PubMed ID: 1776109
[TBL] [Abstract][Full Text] [Related]
7. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
8. Immunoelectron microscopic application of monoclonal antibodies for identification of lymphocyte subsets bearing tubuloreticular inclusions or parallel tubular arrays.
Kang YH; Yaffe L; Grimley PM
J Exp Pathol; 1984; 1(2):157-73. PubMed ID: 6100980
[TBL] [Abstract][Full Text] [Related]
9. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients.
Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M
Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851
[TBL] [Abstract][Full Text] [Related]
10. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
Nies KM; Stevens RH; Louie JS
J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
[TBL] [Abstract][Full Text] [Related]
11. [Markers of peripheral B lymphocytes and their function in IgA nephropathy].
Magyarlaki T; Nagy J; Szabados E; Pár A; Kocsis B
Orv Hetil; 1990 Jul; 131(30):1623-7. PubMed ID: 2205818
[TBL] [Abstract][Full Text] [Related]
12. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE.
Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I
J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between chronic lymphocytic leukaemia (B-CLL) and non-Hodgkin lymphomas in the leukaemic phase by the mouse red blood cell rosette assay.
Pecze K; Telek B; Kiss A; Rak K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):446-50. PubMed ID: 2431964
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia.
Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M
Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317
[TBL] [Abstract][Full Text] [Related]
15. Mouse rosette positive B cells fail to synthesize immunoglobulin following incubation with pokeweed mitogen.
Davey FR; Kurec AS; Lamberson HV
Clin Exp Immunol; 1983 Dec; 54(3):771-7. PubMed ID: 6606517
[TBL] [Abstract][Full Text] [Related]
16. The effect of sera from chronic lymphocytic leukemia patients on normal mitogen-stimulated lymphocytes. A possible correlation with the patients' T and B lymphocytes.
Komlos L; Halbrecht I; Shachor J; Djaldetti M
Exp Hematol; 1978 Aug; 6(7):595-600. PubMed ID: 308462
[TBL] [Abstract][Full Text] [Related]
17. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
18. [The heterogeneity of the immunological phenotype and of the proliferative characteristics of the lymphoid cells in chronic B-cell lympholeukemia].
Kariagin IE; Tsveĭbakh AS; Afanas'ev BV
Vopr Onkol; 1992; 38(6):667-74. PubMed ID: 1300767
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls.
Jacobi AM; Goldenberg DM; Hiepe F; Radbruch A; Burmester GR; Dörner T
Ann Rheum Dis; 2008 Apr; 67(4):450-7. PubMed ID: 17673490
[TBL] [Abstract][Full Text] [Related]
20. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
Morimoto C
Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
